1·Amiodarone, which is used to treat a common heartbeat abnormality, increases the odds that a pacemaker will be needed in women, but not in men, new research suggests.
新研究显示，被用于治疗一种常见心律失常的胺碘酮，增加了女性患者需要安装起搏器的机率，而不是男性。
2·Class III anti - arrhythmic drugs (such as amiodarone) act ia prolongation of the action potential.
II I类抗心律失常药物(例如胺碘酮)是通过延长动作电位来发挥作用的。
3·Objective To compare the effect of sotalol and amiodarone on exercise electrocardiography and hemodynamics.
目的比较索他洛尔与胺碘酮对运动心电图和血流动力学的影响。
4·These observational findings are in contrast to earlier randomized trials of amiodarone and need to be validated prospectively.
这些观察结果与更早期进行的胺碘酮随机化试验相反，这需要将来的进一步验证。
5·CONCLUSION: In this study, amiodarone use was associated with excess early and late all-cause and cardiovascular mortality.
结论：在该研究中，胺碘酮的使用与过早的晚期所有原因引起的心血管死亡率有关。